VEGFA and wet macular degeneration: More aggressive forms of wet AMD, including retinal angiomatous proliferation (RAP), tachyphylaxis to anti-VEGF agents, mimics of wet AMD [41], and underlying genetic differences among patients may contribute to variability in anti-VEGF treatment response [42, 43].